Which brand should you get? CLINICAL MATTERS With the FDA giving the greenlight for the use of boosters among healthcare workers this November, the first legal boosters have already gone into some of the A1 group’s arms, including mine. At the time of this writing, only healthcare workers have...
Ensuring Delta remains under control CLINICAL MATTERS With few exceptions, the biggest one being China, most of the world has pretty much moved on from a COVID-19 elimination strategy. Zero COVID-19, which was the goal early in the pandemic, became a near-impossibility with the rise of the...
Here’s the scientific reason we need them CLINICAL MATTERS Few things are currently as controversial as face shields. With the Philippines being one of the few countries in the world that advocate its use, the face shield has become a hot button topic and reaped a lot of scorn from politicians...
CLINICAL MATTERS Delta plus is a word combination that sent many people into a panic when it was reported in media in October. To those familiar with the havoc that the Delta variant wreaked in India and globally, the only thing that could possibly be worse is the Delta plus. Delta plus, or...
Clinical Matters Nothing is more contentious these days than the discussion surrounding additional doses of COVID-19 vaccines. Israel, having reached a high level of vaccination for its citizens, started offering boosters to its elderly population early on, followed by younger and younger age...
Our economy might’ve taken a hit, but we have one of the lowest mortality rates in the world CLINICAL MATTERS At the start of the pandemic last year, each country had to make hard choices in terms of its response to an unknown virus that was spreading fast. The rapid propagation of what was then...
Here are the new medicines at the forefront in the fight against COVID CLINICAL MATTERS Since the original SARS coronavirus was first discovered in February 2003, scientists have been hard at work looking for effective treatments against deadly coronaviruses. The first promising treatments included...
A quick review of COVID-19 CLINICAL MATTERS Dr. Edsel Maurice T. Salvana The COVID-19 pandemic has changed our lives in many ways. It has also expanded our vocabulary, at least COVID-19-related terms. There remain a lot of misconceptions surrounding technical terms like strain, variant, quarantine,...
(Not just the Western ones) CLINICAL MATTERS Dr. Edsel Maurice T. Salvana Despite record numbers of cases across the world as a result of the Delta variant rampage, death rates from COVID-19 in countries with high vaccination rates have been dropping dramatically. Along with decreasing death rates...
First-generation vaccines are not the boosters you need CLINICAL MATTERS Dr. Edsel Maurice T. Salvana As Delta variant wreaks havoc around the world, many people are starting to worry about their risk for infection and severe COVID-19. Vaccination is proceeding globally at an increasing pace. More...
Each part has its own meaning CLINICAL MATTERS Dr. Edsel Maurice T. Salvana Twenty thousand cases. 22,000 cases. Every day at 4 p.m., people get palpitations waiting for the release of the next Department of Health COVID-19 Bulletin. Most of the attention goes to the number of new cases, followed...
Our early lockdown in March saved 200,000 lives, and continued vaccination is driving down infection numbers CLINICAL MATTERS Dr. Edsel Maurice T. Salvana Last March 2020, the first community transmission of COVID-19 in the Philippines was recorded. Given the uncertainty surrounding the virus, the...
